These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7109011

  • 1. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose.
    Chung DC, Murphy JE, Taylor TW.
    J Toxicol Clin Toxicol; 1982 Apr; 19(2):219-24. PubMed ID: 7109011
    [Abstract] [Full Text] [Related]

  • 2. A "superactive" charcoal for antidotal use in poisonings.
    Cooney DO.
    Clin Toxicol; 1977 Apr; 11(4):387-90. PubMed ID: 589951
    [Abstract] [Full Text] [Related]

  • 3. Does multiple-dose charcoal therapy enhance salicylate excretion?
    Kirshenbaum LA, Mathews SC, Sitar DS, Tenenbein M.
    Arch Intern Med; 1990 Jun; 150(6):1281-3. PubMed ID: 2191636
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model.
    Barone JA, Raia JJ, Huang YC.
    Ann Emerg Med; 1988 Jan; 17(1):34-7. PubMed ID: 3337412
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of two preparations of activated charcoal as adsorbents of aspirin.
    Dawling S, Chand S, Braithwaite RA, Crome P.
    Hum Toxicol; 1983 Apr; 2(2):211-6. PubMed ID: 6862463
    [Abstract] [Full Text] [Related]

  • 6. The adsorption of salicylates by a milk chocolate-charcoal mixture.
    Eisen TF, Grbcich PA, Lacouture PG, Shannon MW, Woolf A.
    Ann Emerg Med; 1991 Feb; 20(2):143-6. PubMed ID: 1996795
    [Abstract] [Full Text] [Related]

  • 7. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE, Gillilan R, Watson WA.
    J Toxicol Clin Toxicol; 1992 Feb; 30(4):549-56. PubMed ID: 1433426
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM, Caraccio TR, Lovejoy FH.
    Clin Pharm; 1982 Feb; 1(2):154-6. PubMed ID: 7185512
    [Abstract] [Full Text] [Related]

  • 9. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK, Jaffe JM, Colaizzi JL, Moriarty RW.
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of commercially available aqueous activated charcoal products.
    Krenzelok EP, Heller MB.
    Ann Emerg Med; 1987 Dec; 16(12):1340-3. PubMed ID: 3688595
    [Abstract] [Full Text] [Related]

  • 11. Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies.
    Hoegberg LC, Angelo HR, Christophersen AB, Christensen HR.
    J Toxicol Clin Toxicol; 2002 Dec; 40(1):59-67. PubMed ID: 11990205
    [Abstract] [Full Text] [Related]

  • 12. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption.
    Keller RE, Schwab RA, Krenzelok EP.
    Ann Emerg Med; 1990 Jun; 19(6):654-6. PubMed ID: 2188536
    [Abstract] [Full Text] [Related]

  • 13. Large surface area activated charcoal and the inhibition of aspirin absorption.
    Dillon EC, Wilton JH, Barlow JC, Watson WA.
    Ann Emerg Med; 1989 May; 18(5):547-52. PubMed ID: 2719366
    [Abstract] [Full Text] [Related]

  • 14. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.
    Neuvonen PJ, Olkkola KT.
    Eur J Clin Pharmacol; 1984 May; 26(6):761-7. PubMed ID: 6489417
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA, Barone J, Giacona N.
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [Abstract] [Full Text] [Related]

  • 16. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
    Sketris IS, Mowry JB, Czajka PA, Anderson WH, Stafford DT.
    J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
    [Abstract] [Full Text] [Related]

  • 17. Interference by tannic acid with the effectiveness of activated charcoal in "universal antidote".
    Daly JS, Cooney DO.
    Clin Toxicol; 1978 Jan; 12(5):515-22. PubMed ID: 679636
    [Abstract] [Full Text] [Related]

  • 18. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA, Fish SS, Lacouture PG, Scavone JM, Lovejoy FH.
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination.
    Ho JL, Tierney MG, Dickinson GE.
    J Clin Pharmacol; 1989 Apr; 29(4):366-9. PubMed ID: 2723125
    [Abstract] [Full Text] [Related]

  • 20. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man.
    Neuvonen PJ, Olkkola KT, Alanen T.
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):1-7. PubMed ID: 6702463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.